Nephros Inc. Reports 36% Increase in Q2 2025 Revenue, Swings to $237K Net Income, EPS at $0.02
Nephros, Inc. reported a 36% increase in Q2 2025 revenue, reaching $4.41 million, up from $3.25 million in Q2 2024. The company swung to a net income of $237,000, compared to a net loss of $289,000 a year earlier. EPS improved to $0.02 from a negative $0.03. Gross margin rose to 63%, and EBITDA was $249,000, up from a negative $275,000. Positive cash flow from operations was $994,000, a significant improvement from a negative $501,000 in Q2 2024. Nephros emphasized its strong balance sheet with no debt and growing recurring revenue.
Nephros, Inc. has reported its financial results for the second quarter of 2025, showcasing a significant increase in revenue and profitability compared to the same period in 2024. The company achieved a revenue of $4.41 million in Q2 2025, up from $3.25 million in Q2 2024. This represents a notable year-over-year growth in revenue. The company’s net income also saw a positive turnaround, with a net profit of $237,000 reported for Q2 2025, compared to a net loss of $289,000 in Q2 2024. Earnings per share (EPS) improved to $0.02 from a negative EPS of $0.03 in the same quarter of the previous year. Nephros, Inc. also highlighted a strong gross margin of 63% for Q2 2025, an improvement from 59% in Q2 2024. The company’s EBITDA for the quarter was $249,000, up from a negative $275,000 in Q2 2024, while adjusted EBITDA was $355,000 compared to a negative $133,000 in the prior year period. In terms of cash flow, the net cash flow from operations was positive, amounting to $994,000 in Q2 2025, a significant improvement from a negative cash flow of $501,000 in Q2 2024. The company also emphasized its strong balance sheet, with no debt, supporting its growth initiatives. Nephros, Inc. continues to benefit from growing recurring revenue from its programmatic subscription customers. No specific outlook or guidance for future periods was provided in the report. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nephros Inc. published the original content used to generate this news brief on August 15, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
